TAIPEI, TAIWAN, Jan. 29, 2021 – Today’s precision medicine demands processing big data quickly and accurately. WASAI Technology partners with Quanta Cloud Technology, QCT to complete the whole genome sequencing within 3 hours by using Intel FPGA D5005 and QCT a Platform on Demon (POD) for medical solution.
Next-generation sequencing (NGS) has brought the revolutionary ability to sequence massive amounts of DNA. With an abundance of data, and the need for processing, management and ultimately analyzing genomic information is at its height for significance and demand. The challenge NGS faces for the secondary analysis stage is to keep up with its massive production of raw data while maintaining accuracy. Time and cost efficiency of resources are also critical issues when addressing complex tasks. Modernizing the infrastructure of servers, racks, storage, and networking is key to realizing medical innovation.
WASAI’s Lighting state-of-the-art genome sequencing acceleration solution enables WGS to be sequenced in less than three hours! Under the collaboration with QCT, a Platform on Demand (POD) solution, provides the infrastructure and data management needed to meet the processing and storage requirements of Next Generation Sequencing (NGS) and DNA sequencing.
Want more exciting information? READ our white paper for further guidance to know how to harness Genomic Precision Medicine with WASAI and QCT highly productive, scalable and configurable Intel FPGA accelerated systems to get insights faster and deeper!
About WASAI Technology Inc.
WASAI Technology's mission is to deliver acceleration technologies of High-Performance Data Analysis (HPDA) in future data centers for targeted vertical applications with massive volumes and high velocities of scientific data. To strengthen and advance scientific discovery and technological research via big data-intensive acceleration in high-performance computing, WASAI Technology aims to improve commercialization and commoditization of scientific and technological applications.